Nanotechnology in Ophthalmology is a comprehensive and up-to-date reference on the role and applications of nanotechnology in ophthalmology, from drug delivery and treatment of ocular diseases to toxicity issues. Written by experts from the nanotechnology, ophthalmology, and pharmacology fields, this book has a unique, broad and diverse scope, including chapters on nanosensor-based diagnostic tools, delivery of nanobiomaterials, implantable materials and devices, delivery of nanobiomaterials, nanotechnology for medical and surgical treatment, regenerative medicine, and more. This book provides a valuable reference to researchers working in the areas of ophthalmology, nanoscience and pharmacology, and clinical fellows who are interested in nanoophthalmology as a reference for their practice and research.
? Provides a comprehensive review of the literature in the area of nanoophthalmology
? Discusses regenerative medicine, drug delivery, imaging, and medical device applications
? Analyzes treatment strategies for emerging and multidrug-resistant ocular pathogens
1. Section I: General introduction - p. xiii 2. Chapter 1. Nanotechnology in the diagnosis of ocular diseases, drug delivery, and therapy: challenges and opportunities - p. 3 3. Section II: Perspectives of nanotechnology in ocular drug delivery - p. 19 4. Chapter 2. An overview of ocular drug delivery systems—conventional and novel drug delivery systems - p. 23 5. Chapter 3. Fathoming biopharmaceutical tenets and characterization techniques for the plausible ophthalmic drug delivery performance - p. 49 6. Section III: Biomedical applications of nanocarriers in ocular diseases, and toxicity - p. 66 7. Chapter 4. Newer nanoformulated peptides in ocular therapeutics: issues and approaches - p. 69 8. Chapter 5. An overview of nanocarriers used in corneal disease - p. 79 9. Chapter 6. Nanomedicine-based solutions: nanoemulsions and nanosuspension for ocular diseases - p. 93 10. Chapter 7. Nanotechnology for surgical glaucoma treatment - p. 103 11. Chapter 8. Nanotechnology in glaucoma—conceptual and clinical treatment aspects - p. 113 12. Chapter 9. Polymeric and lipid nanocarriers in glaucoma - p. 127 13. Chapter 10. Lipid-based nanotherapeutic interventions for the treatment of ocular diseases: current status and future perspectives - p. 151 14. Chapter 11. Nanotechnology in retinal drug delivery - p. 181 15. Chapter 12. Advances in nanotherapies in the management of microbial keratitis - p. 197 16. Chapter 13. Polymeric micelles: a novel treatment option for mycotic keratitis - p. 215 17. Chapter 14. Use of nanotechnology in dry eye syndrome - p. 227 18. Chapter 15. Advances in nanotechnology-based anti-VEGF agents for the management of ocular angiogenesis - p. 247 19. Chapter 16. Application of nanotechnology towards reduction of oxidative stress-induced ocular diseases - p. 263 20. Chapter 17. Nanotechnology in age-related macular degeneration - p. 275 21. Chapter 18. Nanotechnological strategies for the treatment of diabetic retinopathy: progress and limitations - p. 285 22. Chapter 19. Advanced hydrogel-based platform for ocular drug delivery - p. 305 23. Chapter 20. Nanotoxicity in ocular drug delivery - p. 321 24. Index - p. 335
Nanotechnology in Ophthalmology is a comprehensive and up-to-date reference on the role and applications of nanotechnology in ophthalmology, from drug delivery and treatment of ocular diseases to toxicity issues. Written by experts from the nanotechnology, ophthalmology, and pharmacology fields, this book has a unique, broad and diverse scope, including chapters on nanosensor-based diagnostic tools, delivery of nanobiomaterials, implantable materials and devices, delivery of nanobiomaterials, nanotechnology for medical and surgical treatment, regenerative medicine, and more. This book provides a valuable reference to researchers working in the areas of ophthalmology, nanoscience and pharmacology, and clinical fellows who are interested in nanoophthalmology as a reference for their practice and research.
? Provides a comprehensive review of the literature in the area of nanoophthalmology
? Discusses regenerative medicine, drug delivery, imaging, and medical device applications
? Analyzes treatment strategies for emerging and multidrug-resistant ocular pathogens
1. Section I: General introduction - p. xiii 2. Chapter 1. Nanotechnology in the diagnosis of ocular diseases, drug delivery, and therapy: challenges and opportunities - p. 3 3. Section II: Perspectives of nanotechnology in ocular drug delivery - p. 19 4. Chapter 2. An overview of ocular drug delivery systems—conventional and novel drug delivery systems - p. 23 5. Chapter 3. Fathoming biopharmaceutical tenets and characterization techniques for the plausible ophthalmic drug delivery performance - p. 49 6. Section III: Biomedical applications of nanocarriers in ocular diseases, and toxicity - p. 66 7. Chapter 4. Newer nanoformulated peptides in ocular therapeutics: issues and approaches - p. 69 8. Chapter 5. An overview of nanocarriers used in corneal disease - p. 79 9. Chapter 6. Nanomedicine-based solutions: nanoemulsions and nanosuspension for ocular diseases - p. 93 10. Chapter 7. Nanotechnology for surgical glaucoma treatment - p. 103 11. Chapter 8. Nanotechnology in glaucoma—conceptual and clinical treatment aspects - p. 113 12. Chapter 9. Polymeric and lipid nanocarriers in glaucoma - p. 127 13. Chapter 10. Lipid-based nanotherapeutic interventions for the treatment of ocular diseases: current status and future perspectives - p. 151 14. Chapter 11. Nanotechnology in retinal drug delivery - p. 181 15. Chapter 12. Advances in nanotherapies in the management of microbial keratitis - p. 197 16. Chapter 13. Polymeric micelles: a novel treatment option for mycotic keratitis - p. 215 17. Chapter 14. Use of nanotechnology in dry eye syndrome - p. 227 18. Chapter 15. Advances in nanotechnology-based anti-VEGF agents for the management of ocular angiogenesis - p. 247 19. Chapter 16. Application of nanotechnology towards reduction of oxidative stress-induced ocular diseases - p. 263 20. Chapter 17. Nanotechnology in age-related macular degeneration - p. 275 21. Chapter 18. Nanotechnological strategies for the treatment of diabetic retinopathy: progress and limitations - p. 285 22. Chapter 19. Advanced hydrogel-based platform for ocular drug delivery - p. 305 23. Chapter 20. Nanotoxicity in ocular drug delivery - p. 321 24. Index - p. 335
